Atomoxetine, a selective norepinephrine inhibitor, is effective in comorbid anxiety and attention deficit hyperactivity disorder, however its role in panic disorder is unknown. We are presenting a case of panic disorder, who initially partially responded to clonazepam. When clonazepam was added with sertraline, escitalopram, desvenlafaxin, she did not improve significantly until paroxetine was added. When clonazepam-paroxetine combination was added with propranolol, etizolam, olanzepine, risperidone and amisulpride the symptom remission did not occur until a trial of Atomoxetine was done.
CITATION STYLE
Ram, D., Patil, S., Gowdappa, B., & Rajalakshmi, I. (2015). Atomoxetine augmentation in a case of treatment resistant panic disorder with multiple augments failure: A case report. Clinical Psychopharmacology and Neuroscience, 13(3), 321–323. https://doi.org/10.9758/cpn.2015.13.3.321
Mendeley helps you to discover research relevant for your work.